1
|
65
|
M
|
Postoperative after AAA
|
Haloperidol, sufentanil, midazolam
|
10
|
10
|
8
|
− 1
|
7.41
|
37.5
|
2
|
64
|
F
|
COPD Gold I
|
Haloperidol
|
10
|
8
|
27
|
0
|
7.43
|
51.0
|
3
|
70
|
M
|
Bilateral pneumonia
|
Haloperidol
|
10
|
6
|
22
|
− 2
|
7.42
|
58.5
|
4
|
68
|
M
|
Hypoxemia, suspected aeCOPD
|
Haloperidol
|
10
|
5
|
28
|
0
|
7.49
|
40.5
|
5
|
67
|
M
|
CABG
|
Haloperidol, dexmedetomidine, sufentanil
|
10
|
10
|
21
|
0
|
7.50
|
41.3
|
6
|
71
|
M
|
COPD Gold III
|
Oxazepam
|
10
|
5
|
45
|
0
|
7.45
|
64.5
|
7
|
69
|
M
|
CABG, PJP
|
–
|
8
|
6
|
11
|
− 1
|
7.42
|
58.5
|
8
|
68
|
M
|
Pneumonia, COPD Gold III
|
Haloperidol, sufentanil
|
10
|
5
|
3
|
− 3
|
7.48
|
32.3
|
9
|
65
|
M
|
CABG
|
Haloperidol, sufentanil
|
10
|
6
|
19
|
0
|
7.52
|
36.0
|
10
|
46
|
M
|
Bentall procedure
|
Midazolam, sufentanil
|
10
|
8
|
3
|
− 4
|
7.36
|
38.3
|
11
|
62
|
M
|
Septic profile, ARDS
|
Haloperidol, oxazepam, sufentanil
|
10
|
6
|
15
|
NA
|
7.44
|
35.3
|
12
|
59
|
F
|
COPD Gold II
|
Remifentanil
|
10
|
5
|
7
|
NA
|
7.43
|
42.8
|
13
|
65
|
F
|
aeCOPD Gold III
|
Midazolam, sufentanil
|
10
|
5
|
8
|
− 2
|
7.48
|
51.0
|
14
|
75
|
F
|
Hypercapnic coma, weaning problems
|
–
|
0
|
10
|
20
|
0
|
7.42
|
50.3
|
15
|
52
|
M
|
Mediastinitis, COPD Gold II
|
Haloperidol
|
0
|
8
|
35
|
− 2
|
NA
|
NA
|
16
|
69
|
M
|
aeCOPD Gold III
|
Haloperidol, midazolam, sufentanil
|
10
|
5
|
3
|
− 2
|
7.45
|
42.0
|
17
|
47
|
F
|
Weaning problems
|
–
|
8
|
5
|
20
|
0
|
7.41
|
67.5
|